why choose us

Clinical Trials Search

Showing 17,490 of 132,963 result(s)
Tau PET;CT Imaging in the Mismatch Prospective Cohort Study (MPC-TAU)

Status: Completed

Condition: Alzheimer's Disease

Interventions: This is a cross-sectional study using the radiotracer AV-1451 to determine the relationship of tau pathology to other biomarker data of MPC participan

Date: 2022-12-08

Kenota 1 CWS Method Comparison Validation Study

Status: COMPLETED

Condition: Allergy

Interventions: The Kenota 1 System is intended to be a specialized tool in a professional allergist setting.
It will help streamline the patient testing process

Date: 2022-12-08

Evaluation of Lymphodepletion With ALLO-647 in Adults With R;R Large B Cell Lymphoma Receiving ALLO-501A Allogeneic CAR T Cell Therapy

Status: Completed

Condition: Relapsed;Refractory Large B Cell Lymphoma

Interventions: ALLO-647 is a monoclonal antibody that recognizes a CD52 antigen

Date: 2022-12-08

Linking Emergency Department Patients to Assistance Programs Study

Status: Completed

Condition: Social Determinants of Health

Interventions: A text messaging intervention will be conducted that includes prompts to call trained BenePhilly enrollment specialists to submit applications for ben

Date: 2022-12-08

A Study of BLB-201 RSV Vaccine in Infants and Children

Status: Completed

Condition: Respiratory Syncytial Virus Infections

Interventions: BLB201 10^6 PFU

Date: 2022-12-08

Use of Micropulse Trans-Scleral Cyclophotocoagulation Laser (MP-TSCPC) for Glaucoma Patients

Status: Completed

Condition: Glaucoma

Interventions:

Date: 2022-12-08

CardioSeq: Impact of WGS in Individuals With CVD

Status: Completed

Condition: Cardiovascular Diseases

Interventions: The TruGenome Cardiovascular Disease (CVD) test which consists of an in-silico 200 gene cardiovascular disease panel, a further 4 genes with cardiovas

Date: 2022-12-08

Study to Evaluate ARINA-1 in the Prevention of Bronchiolitis Obliterans Progression in Participants With Bilateral Lung Transplant

Status: Completed

Condition: Pre-Bronchiolitis Obliterans Syndrome

Interventions: ARINA-1 (88 mg;mL ascorbic acid, ASC; 150 mg;mL reduced glutathione, GSH)

Date: 2022-12-08

COGNITION: Genomics-Guided Precision Oncology in Early High-Risk Breast Cancer

Status: Completed

Condition: Early-Stage Breast Cancer

Interventions: Procedure: genomic profiling (Whole-Genome- ; Exome-Sequencing + RNA-Sequencing) in high-risk early breast cancer patients pre- and post neoadjuv

Date: 2022-12-08

NAVA in Infants With Acute Viral Bronchiolitis: A Feasibility Study

Status: COMPLETED

Condition: Acute Viral Bronchiolitis

Interventions: NAVA mode will be titrated as per protocol alongside titration of PEEP levels.
Peep will be titrated for all NAVA levels in a descending order 10

Date: 2022-12-08